Ketoconazole in experimental candidosis

Area of Science:

• Mycology and Infectious Diseases
• Pharmacology and Toxicology

Background:

• Candidosis, a fungal infection caused by Candida species, poses a significant health concern.
• Numerous animal models are available for evaluating antifungal drug efficacy across different infection sites.

Purpose of the Study:

• To assess the efficacy of ketoconazole in treating candidosis using established animal models.
• To investigate the effectiveness of both oral and topical ketoconazole administration.

Main Methods:

• Utilized a variety of animal models simulating candidosis of the skin, gastrointestinal tract, genital system, and internal organs.
• Administered ketoconazole both orally and topically to infected animals.
• Employed scanning and transmission electron microscopy to visualize fungal eradication in host tissues.

Main Results:

• Ketoconazole demonstrated significant efficacy when administered orally, even at relatively low doses.
• The antifungal effect was observed across all experimental candidosis models tested.
• Electron microscopy confirmed the rapid eradication of Candida albicans from infected tissues following ketoconazole treatment.

Conclusions:

• Ketoconazole is a highly efficacious antifungal agent for treating candidosis in diverse animal models.
• Oral ketoconazole provides a rapid and effective treatment option for systemic and localized Candida infections.
• The findings support ketoconazole's potential as a therapeutic agent for candidosis in clinical settings.